MOMENTA PHARMACEUTICALS INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for MOMENTA PHARMACEUTICALS INC (MNTA), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are MNTA insiders buying or selling?
MOMENTA PHARMACEUTICALS INC insiders reported 0 open-market buys ($0) and 260 sells ($54.2M) across 260 Form 4 filings — a net selling position of $54.2M.
Source: SEC EDGAR Form 4
Key Statistics (as of Aug 21, 2020)
Insider sentiment
Net sellingNet insider flow of $54.2M in net selling.
Recent MNTA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 21, 2020 | Ian Fier | Chief Mfg and Program Officer | Sale | 1.8K | $52.17 | $94.3K |
| Aug 20, 2020 | Jose-Carlos Gutierrez-Ramos | Director | Sale | 10.0K | $52.09 | $520.9K |
| Aug 13, 2020 | Anthony M. Manning | Chief Scientific Officer | Sale | 403 | $29.31 | $11.8K |
| Aug 13, 2020 | Craig A Wheeler | President & CEO | Sale | 2.8K | $28.55 | $79.3K |
| Aug 13, 2020 | JO Ann Beltramello | Chief HR and Inf. Officer | Sale | 6.9K | $28.02 | $194.0K |
| Aug 11, 2020 | Anthony M. Manning | Chief Scientific Officer | Sale | 347 | $32.36 | $11.2K |
| Aug 11, 2020 | Young Kwon | Chief Financial & Bus. Officer | Sale | 652 | $32.36 | $21.1K |
| Aug 11, 2020 | Ian Fier | Chief Mfg and Program Officer | Sale | 330 | $32.36 | $10.7K |
| Aug 11, 2020 | JO Ann Beltramello | Chief HR and Inf. Officer | Sale | 3.3K | $32.07 | $106.2K |
| Aug 11, 2020 | Craig A Wheeler | President & CEO | Sale | 2.6K | $31.21 | $81.2K |
| Aug 7, 2020 | Steven C Gilman | Director | Sale | 13.0K | $32.75 | $425.8K |
| Aug 7, 2020 | Georges Gemayel | Director | Sale | 10.0K | $33.00 | $330.0K |
| Aug 6, 2020 | Santiago Arroyo | SVP, Chief Medical Officer | Sale | 34.6K | $32.25 | $1.1M |
| Aug 6, 2020 | Ian Fier | Chief Mfg and Program Officer | Sale | 25.0K | $32.76 | $818.0K |
| Jul 30, 2020 | Santiago Arroyo | SVP, Chief Medical Officer | Sale | 39.6K | $30.00 | $1.2M |
| Jul 30, 2020 | Georges Gemayel | Director | Sale | 10.0K | $30.00 | $300.0K |
| Jul 30, 2020 | Steven C Gilman | Director | Sale | 10.0K | $29.70 | $297.0K |
| Jul 28, 2020 | Santiago Arroyo | SVP, Chief Medical Officer | Sale | 681 | $30.00 | $20.4K |
| Jul 28, 2020 | JO Ann Beltramello | Chief HR and Inf. Officer | Sale | 1.2K | $30.00 | $36.6K |
| Jul 23, 2020 | Steven C Gilman | Director | Sale | 10.0K | $33.23 | $332.3K |
| Jul 23, 2020 | Ian Fier | Chief Mfg and Program Officer | Sale | 33.5K | $32.48 | $1.1M |
| Jul 23, 2020 | Anthony M. Manning | Chief Scientific Officer | Sale | 1.9K | $34.69 | $67.3K |
| Jul 23, 2020 | Santiago Arroyo | SVP, Chief Medical Officer | Sale | 51.9K | $34.53 | $1.8M |
| Jul 21, 2020 | Santiago Arroyo | SVP, Chief Medical Officer | Sale | 1.6K | $33.95 | $53.0K |
| Jul 21, 2020 | Anthony M. Manning | Chief Scientific Officer | Sale | 51.1K | $33.91 | $1.7M |
Showing the 25 most recent of 260 Form 4 filings for MOMENTA PHARMACEUTICALS INC.
Most active MNTA insiders
- JO Ann Beltramello43 filings
- Ian Fier40 filings
- Craig A Wheeler38 filings
- Young Kwon38 filings
- Anthony M. Manning36 filings
Ask anything about MNTA insider activity
Use Trabud's AI agent to query MOMENTA PHARMACEUTICALS INC's Form 4 history in plain English — "Show me MNTA CEO purchases this year" or compare it against any other ticker.
Open the AI agentMNTA insider trading FAQ
Are MOMENTA PHARMACEUTICALS INC insiders buying or selling?
Across 260 SEC Form 4 filings, MOMENTA PHARMACEUTICALS INC (MNTA) insiders reported 0 open-market purchases totaling $0 and 260 sales totaling $54.2M. That is a net selling position of $54.2M.
How many insiders trade MNTA stock?
16 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for MOMENTA PHARMACEUTICALS INC. The most recent filing was accepted on Aug 21, 2020.
Where does Trabud get MNTA insider trading data?
All MNTA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.